WebJan 25, 2006 · This guidance has been updated and replaced by cardiovascular disease: risk assessment and reduction, including lipid modification WebJan 28, 2016 · They also recommended statins in those aged 30–40 years with any of the following features: long duration of disease; poor control; persistent albuminuria or eGFR <60ml/min; proliferative retinopathy; treated hypertension; current smoking; autonomic neuropathy; raised total cholesterol or reduced HDL cholesterol; central obesity; or a …
Statin Therapy in Older Adults for Primary Prevention of ...
WebJan 12, 2024 · Draft updated guidance from NICE published today (12 January 2024) recommends that the risk threshold at which statins should be offered to prevent … WebJan 15, 2024 · Based on study findings, statin therapy may be recommended for primary prevention of cardiovascular events in patients with or without diabetes and a 10-year ASCVD risk of at least 7.5%... fire helmet sun hat
Scenario: Lipid therapy - primary prevention of CVD - CKS NICE
WebMay 4, 2024 · Refer to the lipid management algorithm and related NICE guidelines (CG71, CG181) for guidance on initiation, titration, and monitoring of statin therapy. Statin Intolerance Pathway Algorithm 1: Statin Intolerance Pathway Definition of Statin Intolerance. Intolerance to initial statin therapy is defined by NICE as the presence of clinically ... WebMeasure total cholesterol, high-density lipoprotein cholesterol (HDL-C), and non-HDL-C (total cholesterol minus HDL cholesterol) levels in all people after 3 months of high-intensity statin treatment. The aim of treatment is to achieve a greater than 40% reduction in baseline non-HDL-C levels. WebMar 20, 2024 · Adults ages 40-75 with diabetes and an LDL cholesterol level of 70-189 mg/dL should be treated with moderate-intensity statin therapy. Patients 75 and younger who have clinical ASCVD should... ether grid